Stiff Person Syndrome Treatment in Women Planning or During Early Pregnancy
Managing Stiff Person Syndrome requires careful individualisation when the patient is planning pregnancy or is already in early pregnancy. This scenario calls for a specific treatment approach that accounts for fetal safety alongside disease control.
Female patient with Stiff Person Syndrome who is planning pregnancy or is currently in early pregnancy. The therapeutic decision must balance adequate disease management with the safety profile of each treatment option for the developing fetus.
The recommended first-line strategy in this setting involves intravenous immunoglobulin (IVIg), prioritised specifically because of fetal safety considerations — initiating it as early as possible is emphasised.
Dosing, schedule, monitoring, and the full clinical algorithm are available in the complete protocol below.References
DOI: 10.1212/NXI.0000000000200109
For women planning pregnancy or in early pregnancy, it is highly advisable to start IVIG as early as possible to improve function and avoid any potential effects of GABA enhancers to the fetus.
View source ↗